ArticleMolecular therapy. Oncology2024

CAR'TCR-T cells co-expressing CD33-CAR and dNPM1-TCR as superior dual-targeting approach for AML treatment.

Karin Teppert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.